FDA Approved: SYMPROIC — Supplemental Application (BioDelivery Sciences International Inc)

View source ↗

Summary

FDA approved a supplemental application for Symproic (nalmefene) submitted by BioDelivery Sciences International Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• SYMPROIC (NALDEMEDINE)

Snippet

SUPPL AP for SYMPROIC (NALDEMEDINE)